Atrovent 250 mcg/2 ml

Atrovent 250 mcg/2 ml is a medicine authorised by Swissmedic under authorisation number 52584. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 November 1994 and the authorisation is valid without a time limit. ATC code R03BB01 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 52584
  • ATC R03BB01
  • Synthetic medicines
Authorisation data
Authorisation number52584
NameAtrovent 250 mcg/2 ml
Full nameAtrovent 250 mcg/2 ml, Lösung für einen Vernebler (gebrauchsfertige Einzeldosen)
Authorisation holderBoehringer Ingelheim (Schweiz) GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeR03BB01
First authorisation15 November 1994
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Atrovent 250 mcg/2 ml, Lösung für einen Vernebler (gebrauchsfertige Einzeldosen)B15 November 1994

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1960Einzeldose(n)R03BB0103.04.3.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Atrovent 250 mcg/2 ml authorised in Switzerland?

Yes. Atrovent 250 mcg/2 ml is authorised by Swissmedic under authorisation number 52584, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Atrovent 250 mcg/2 ml have?

Atrovent 250 mcg/2 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Atrovent 250 mcg/2 ml?

The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com